We are live on ! Find out more

3,435 hedge funds and large institutions have $216B invested in Merck in 2023 Q4 according to their latest regulatory filings, with 378 funds opening new positions, 1,245 increasing their positions, 1,486 reducing their positions, and 107 closing their positions.

New
Increased
Maintained
Reduced
Closed

253% more first-time investments, than exits

New positions opened: 378 | Existing positions closed: 107

10% more call options, than puts

Call options by funds: $1.92B | Put options by funds: $1.75B

9% more capital invested

Capital invested by funds: $199B → $216B (+$17.4B)

7% more funds holding

Funds holding: 3,2143,435 (+221)

2.47% more ownership

Funds ownership: 75.65%78.12% (+2.5%)

5% less funds holding in top 10

Funds holding in top 10: 186177 (-9)

16% less repeat investments, than reductions

Existing positions increased: 1,245 | Existing positions reduced: 1,486

Holders
3,435
Holders Change
+221
Holders Change %
+6.88%
% of All Funds
50.07%
Holding in Top 10
177
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-4.84%
% of All Funds
2.58%
New
378
Increased
1,245
Reduced
1,486
Closed
107
Calls
$1.92B
Puts
$1.75B
Net Calls
+$175M
Net Calls Change
-$230M
Name Holding Trade Value Shares
Change
Change in
Stake
SHFA
1026
SS&H Financial Advisors
Michigan
$5.23M +$31.1K +300 +0.6%
LIM
1027
Letson Investment Management
Georgia
$5.22M +$4.97M +47,880 New
DWT
1028
Dorsey & Whitney Trust
South Dakota
$5.19M +$486K +4,681 +11%
CNBTD
1029
Citizens National Bank Trust Department
Mississippi
$5.19M +$50.6K +487 +1%
PTC
1030
Philadelphia Trust Company
Pennsylvania
$5.19M -$2.6K -25 -0.1%
LCM
1031
Legato Capital Management
California
$5.19M
BMA
1032
Brooks Moore & Associates
Tennessee
$5.19M -$17.4K -168 -0.4%
AC
1033
Abbrea Capital
California
$5.18M +$27K +260 +0.6%
PT
1034
Plimoth Trust
Massachusetts
$5.17M +$110K +1,060 +2%
MFG
1035
Monte Financial Group
Connecticut
$5.17M +$454K +4,373 +10%
OGC
1036
Oak Grove Capital
New Hampshire
$5.16M +$2.82M +27,193 +135%
CA
1037
Commerzbank Aktiengesellschaft
Germany
$5.15M +$1.4M +13,441 +40%
PMSA
1038
Patrick M. Sweeney & Associates
Illinois
$5.15M +$4.9M +47,238 New
HIC
1039
Holderness Investments Company
North Carolina
$5.15M +$1.14M +11,022 +30%
LC
1040
Legacy CG
Texas
$5.13M +$731K +7,044 +18%
WAP
1041
Wealthcare Advisory Partners
Pennsylvania
$5.12M +$52.4K +505 +1%
VWM
1042
Valley Wealth Managers
New Jersey
$5.12M -$88K -848 -2%
AF
1043
Allworth Financial
California
$5.11M +$329K +3,173 +7%
RMAM
1044
Raab & Moskowitz Asset Management
New Jersey
$5.1M +$17.8K +171 +0.4%
BIM
1045
Bridges Investment Management
Nebraska
$5.1M +$176K +1,698 +4%
PAI
1046
Pittenger & Anderson Inc
Nebraska
$5.1M +$13.7K +132 +0.3%
HCM
1047
Hilton Capital Management
New York
$5.08M -$1.66K -16 -0%
SSB
1048
Sandy Spring Bank
Maryland
$5.08M -$112K -1,075 -2%
WWS
1049
Wellington Wealth Strategies
Indiana
$5.07M +$4.83M +46,504 New
FM
1050
Foster & Motley
Ohio
$5.06M -$104K -1,000 -2%

MRK Hedge Fund Activity: Q4 2023 in Review

3,435 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2023, worth a combined $216B — up 8.8% from $199B a quarter earlier.

Buyers outnumbered sellers: 378 funds opened new MRK positions and 107 closed out — a net gain of 271 holders — while 1,245 added to existing stakes and 1,486 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $4.32B. The largest seller was Bank of New York Mellon, cutting an estimated $432M.

  • 3,435 institutional investors held Merck (MRK) as of Q4 2023, up from 3,214 in Q3 2023.
  • Funds reported $216B of Merck stock for Q4 2023, up 8.8% quarter-over-quarter.
  • 378 funds opened new Merck positions in Q4 2023 and 107 closed out, a net change of +271 holders.
  • The largest Merck buyer in Q4 2023 was Morgan Stanley, an estimated $4.32B added.
  • The largest Merck seller in Q4 2023 was Bank of New York Mellon, an estimated $432M sold.

Based on aggregated 13F filings for Q4 2023.